Jackson, A. M., Williams, K., Stempora, L., Song, S., Kelsoe, G. H., Lee, F., … Knechtle, S. J. (2023). Early Results of the Adapt Desensitization Trial in Kidney Transplant (tx) Candidates with 100% Cpra: Impact of Carfilzomib and Belatacept. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 23, pp. S374–S374).

Jackson, A. M., K. Williams, L. Stempora, S. Song, G. H. Kelsoe, F. Lee, D. C. Nguyen, et al. “Early Results of the Adapt Desensitization Trial in Kidney Transplant (tx) Candidates with 100% Cpra: Impact of Carfilzomib and Belatacept.” In AMERICAN JOURNAL OF TRANSPLANTATION, 23:S374–S374, 2023.

Jackson AM, Williams K, Stempora L, Song S, Kelsoe GH, Lee F, et al. Early Results of the Adapt Desensitization Trial in Kidney Transplant (tx) Candidates with 100% Cpra: Impact of Carfilzomib and Belatacept. In: AMERICAN JOURNAL OF TRANSPLANTATION. 2023. p. S374–S374.

Jackson, A. M., et al. “Early Results of the Adapt Desensitization Trial in Kidney Transplant (tx) Candidates with 100% Cpra: Impact of Carfilzomib and Belatacept.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 23, no. 6, 2023, pp. S374–S374.

Jackson AM, Williams K, Stempora L, Song S, Kelsoe GH, Lee F, Nguyen DC, Mason K, Chandran S, Da Silva JF, Breeden C, Sanoff S, Knechtle SJ. Early Results of the Adapt Desensitization Trial in Kidney Transplant (tx) Candidates with 100% Cpra: Impact of Carfilzomib and Belatacept. AMERICAN JOURNAL OF TRANSPLANTATION. 2023. p. S374–S374.